Skip to main content

FIIs pare stake in 30 stocks with m-cap of over Rs 50,000 crore; time to turn cautious?

 The 31 companies where FIIs have pared their holdings include Infosys, HDFC, ICICI Bank, ITC, Bharti Airtel, Bajaj Finserv, Titan Company, Eicher Motors and Tata Steel.

Foreign institutional investors (FIIs) pared stake sequentially in some of the prominent large-cap companies in the June quarter, data from AceEquity showed

From the universe of companies having a market capitalisation of more than Rs 50,000 crore, there are as many as 31 names in which FIIs pared their holdings. These include Infosys, HDFC, ICICI Bank, ITC, Bharti Airtel, Bajaj Finserv, Titan Company, Eicher Motors and Tata Steel.

Out of 31 companies, 19 have been trading lower so far in 2020. These include SBI, Coal India, ITC, Tata Steel, Tech Mahindra and IOC.

The rest 11 companies have given positive returns in 2020 so far, including Divi’s Laboratories, Dr. Reddy’s Laboratories, Infosys, Britannia, and HCL Technologies.



Does that mean that investors should turn cautious?

Well, experts are of the view that if we look at the data, FIIs have reduced the stake marginally which could be attributed to the rebalancing of portfolio, or booking profits amid the rise in valuations. Hence, the paring of the stake should not be viewed negatively.

“In most of the large-cap names where FIIs have reduced exposure the percentage reduction is very miniscule. This could be due to the continued selling and rotation seen in April even after the March month selling,” Rusmik Oza, Executive Vice President, Head of Fundamental Research at Kotak Securities told Moneycontrol.

“One cannot infer or draw any conclusion that these companies' growth model has become weak because of the minor reduction in FII holding. At times we see a rotation of flows within the large-cap space and last three months have been exceptional due to the pandemic crisis,” he said.

Oza further added that some of the minor reduction in exposure can get corrected in the September quarter as many of the laggards and underperforming large caps have rebounded sharply in July and August.

Other factors to track:

Tracking what Foreign institutional investors are doing is a good thing, but that should not be the only basis of making a buy or sell decision, suggest experts.

Investors should ideally see a trend for 3-4 quarters rather than basing their decision on statistics of one quarter, they say. There may be many factors why FIIs decided to reduce stake; hence, investors should do their own research before pressing buy or a sell button.

“There are many NIFTY-50 heavyweights where we have witnessed reduced exposure of FIIs but growth might play a vital role in the future and might drive benchmark indices. In my opinion, investors should wait at least 2-3 quarters before making any decision and question on a growth model,” Gaurav Garg, Head of Research at CapitalVia Global Research Limited told Moneycontrol.

“Investors should look for a good business driven by a good set of people who will always deliver good returns in the longer run. Corporate governance plays an important role when it comes to the sustainability of the business. Higher potential in earnings growth is always a good sign to invest in stock and hold for the long run,” he said.

Ajit Mishra, VP Research, Religare Broking told Moneycontrol that apart from FII holding, investors must look at various other factors such as its fundamental track record, financial leverage, and return ratios (particularly debt to equity).

“Further, it has also become very important to check on whether the company is facing any corporate governance issues as this leads to sharp valuation correction. Also, buying/selling would depend on what valuations the investor is interested in the stock and whether it is justified,” he said.

Disclaimer: The views and investment tips expressed by experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com/SD Solutions advises users to check with certified experts before taking any investment decisions.

Comments

Popular posts from this blog

Panacea Biotech shares hit 5% upper circuit after dengue vaccine completes phase I & II study

DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes, the company has said in an exchange filing. Panacea Biotech share price hit 5 percent upper circuit on the BSE on September 24 after the company completed phases I and II study of its dengue vaccine candidate DengiAIl. "Panacea Biotec Ltd. is delighted to announce the successful completion of its Phase I/II study to evaluate the safety and immunogenicity of its vaccine, DengiAll, a single-dose liveattenuated tetravalent vaccine," the company said in an exchange filing. Live-attenuated vaccines contain weakened bacteria or viruses that trigger an immune response but do not cause disease. The company said DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes. DengiAIl has been found to be safe and well-tolerated with no serious adverse effects, the company said. After a single-dose, more than 80 percent of the participants ...

Brokerages place bets on Titan, see double-digit upside in the stock

Titan can get benefits from the strong market share in the jewellery and wrist watches segment, mainly driven by a wide range of product portfolio catering mainly to the premium and value-added designer jewellery segment. After three consecutive sessions of losses, shares of Titan Company rose over a percent in morning trade on BSE on September 23. The company was dealt a severe blow by COVID-19 as the pandemic triggered strict lockdowns completely battered the retail sector. In the calendar year so far, shares of this one of the largest, most efficient and profitable specialty retailer in India are 7 percent down. The company reported a net standalone loss of Rs 270 crore for the quarter ended June 2020 as the COVID-19 pandemic hit business. The loss was higher than a CNBC-TV18 poll estimate of Rs 175 crore. Standalone revenue during the quarter declined 62.3 percent year-on-year to Rs 1,862 crore compared to the corresponding period last fiscal. Light at the end ...

Indigo Paints trades at over 55% premium in grey market after IPO price announcement

The grey market premium has increased significantly from Rs 400-500 on January 11 to Rs 840-850 on January 15. Indigo Paints, one of the fastest-growing paint companies in India, was trading at more than 50 percent premium over its higher issue price band of Rs 1,490 per share in the grey market after the announcement of IPO details. The premium in the grey market as of January 15 was at around Rs 840-850 per share, which means the grey market trading price stood at Rs 2,340-2,330 against the issue price of Rs 1,490, as per the data available on IPO Watch. The premium increased significantly from Rs 400-500 on January 11 to Rs 840-850 today. The grey market is an unofficial trading platform where shares get traded well before the allotment in an initial public offering and till the shares get listed on bourses. It generally estimates the expected listing price of a stock. "Currently Asian paints and Berger paints are trading at a PE of 111 and 148, respectively, while Indigo Paint...